In 2020 Decentralized Clinical Trials (DCT’s) went from edge case to main case, ushering in a new era of clinical trials. This era is democratizing access to clinical trials by removing the barriers posed by time, travel, and more. Medable has led the movement to decentralize clinical trials with over 150 DCT’s to date. Expanding access by modernizing the clinical trial experience is leading to the consumerization of clinical trials. Keys to modernizing:
This session shares insights and examples that highlight how the consumerization of trials will democratize and modernize clinical development.
Tyler Pugsley, Medable’s Vice President of Life Sciences has almost a decade of experience partnering with pharmaceutical sponsors and...